CD8A and neoplasm: High-risk patients, as identified by our model, exhibited diminished infiltration of anti-tumor immune cells, including effector memory CD8 + T cells, NK cells, and Th1 cells, alongside increased infiltration of Th2 cells, which antagonize Th1 cell responses.